Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

A biallelic mutation links MYORG to autosomal-recessive primary familial brain calcification.

Forouhideh Y, Müller K, Ruf W, Assi M, Seker T, Tunca C, Knehr A, Strom TM, Gorges M, Schradt F, Meitinger T, Ludolph AC, Pinkhardt EH, Basak AN, Kassubek J, Uttner I, Weishaupt JH.

Brain. 2019 Feb 1;142(2):e4. doi: 10.1093/brain/awy343. No abstract available.

PMID:
30649222
2.

Two histological methods for recognition and study of cortical microinfarcts in thick sections.

Braak H, Feldengut S, Kassubek J, Yilmazer-Hanke D, Del Tredici K.

Eur J Histochem. 2018 Dec 20;62(4). doi: 10.4081/ejh.2018.2989.

3.

On Razor's edge: Managing analgosedation during severe anti-NMDA receptor encephalitis.

Jesse S, Wagner J, Gastl R, Steinacker P, Otto M, Kassubek J, Lewerenz J.

Neurol Neuroimmunol Neuroinflamm. 2018 Nov 19;6(1):e522. doi: 10.1212/NXI.0000000000000522. eCollection 2019 Jan. No abstract available.

4.

The applause sign in frontotemporal lobar degeneration and related conditions.

Schönecker S, Hell F, Bötzel K, Wlasich E, Ackl N, Süßmair C; German FTLD Consortium, Otto M, Anderl-Straub S, Ludolph A, Kassubek J, Huppertz HJ, Diehl-Schmid J, Riedl L, Roßmeier C, Fassbender K, Lyros E, Kornhuber J, Oberstein TJ, Fliessbach K, Schneider A, Schroeter ML, Prudlo J, Lauer M, Jahn H, Levin J, Danek A.

J Neurol. 2019 Feb;266(2):330-338. doi: 10.1007/s00415-018-9134-y. Epub 2018 Dec 1.

PMID:
30506397
5.

Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions.

Forsberg KME, Zhang Y, Reiners J, Ander M, Niedermayer A, Fang L, Neugebauer H, Kassubek J, Katona I, Weis J, Ludolph AC, Del Tredici K, Braak H, Yilmazer-Hanke D.

Acta Neuropathol Commun. 2018 Nov 23;6(1):128. doi: 10.1186/s40478-018-0632-z.

6.

Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-centre tract of interest-based DTI analysis.

Müller HP, Agosta F, Gorges M, Kassubek R, Spinelli EG, Riva N, Ludolph AC, Filippi M, Kassubek J.

Neuroimage Clin. 2018;20:1062-1069. doi: 10.1016/j.nicl.2018.10.005. Epub 2018 Oct 9.

7.

Analysis of CACNA1A CAG repeat lengths in patients with familial ALS.

Brenner D, Müller K, Gastl R, Gorges M, Otto M, Pinkhardt EH, Kassubek J, Weishaupt JH, Ludolph AC.

Neurobiol Aging. 2019 Feb;74:235.e5-235.e8. doi: 10.1016/j.neurobiolaging.2018.09.019. Epub 2018 Sep 22.

PMID:
30342765
8.

Corticoefferent pathology distribution in amyotrophic lateral sclerosis: in vivo evidence from a meta-analysis of diffusion tensor imaging data.

Gorges M, Del Tredici K, Dreyhaupt J, Braak H, Ludolph AC, Müller HP, Kassubek J.

Sci Rep. 2018 Oct 18;8(1):15389. doi: 10.1038/s41598-018-33830-z.

9.

MRI-Based Mapping of Cerebral Propagation in Amyotrophic Lateral Sclerosis.

Müller HP, Kassubek J.

Front Neurosci. 2018 Sep 26;12:655. doi: 10.3389/fnins.2018.00655. eCollection 2018.

10.

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.

Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S, Tumani H, von Arnim CAF, Dorst J, Feneberg E, Mayer B, Müller HP, Gorges M, Rosenbohm A, Volk AE, Silani V, Ludolph AC, Otto M.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):157-164. doi: 10.1136/jnnp-2018-318704. Epub 2018 Oct 11.

PMID:
30309882
11.

Serum GFAP as a biomarker for disease severity in multiple sclerosis.

Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M.

Sci Rep. 2018 Oct 4;8(1):14798. doi: 10.1038/s41598-018-33158-8.

12.

Serum neurofilament light chain in behavioral variant frontotemporal dementia.

Steinacker P, Anderl-Straub S, Diehl-Schmid J, Semler E, Uttner I, von Arnim CAF, Barthel H, Danek A, Fassbender K, Fliessbach K, Foerstl H, Grimmer T, Huppertz HJ, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Maler JM, Mayer B, Oeckl P, Prudlo J, Schneider A, Volk AE, Wiltfang J, Schroeter ML, Ludolph AC, Otto M; FTLDc study group.

Neurology. 2018 Oct 9;91(15):e1390-e1401. doi: 10.1212/WNL.0000000000006318. Epub 2018 Sep 12.

PMID:
30209235
13.

Targeting head movements in humans: Compensation for disturbance from simultaneous body rotations.

Becker W, Kassubek J, Maurer C, Mergner T.

Hum Mov Sci. 2018 Oct;61:197-218. doi: 10.1016/j.humov.2018.08.007. Epub 2018 Sep 3.

PMID:
30189333
14.

[Botulinum toxin for neurogenic dysphagia after brainstem ischemia : Single injection as a treatment of an esophageal opening disorder].

Schradt F, Stösser S, Hänle M, Kassubek J, Lindner-Pfleghar B, Neugebauer H.

Nervenarzt. 2019 Feb;90(2):191-193. doi: 10.1007/s00115-018-0603-4. German. No abstract available.

PMID:
30171305
15.

Acute DWI Reductions In Patients After Single Epileptic Seizures - More Common Than Assumed.

Hübers A, Thoma K, Schocke M, Fauser S, Ludolph AC, Kassubek J, Pinkhardt EH.

Front Neurol. 2018 Jul 25;9:550. doi: 10.3389/fneur.2018.00550. eCollection 2018.

16.

Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.

Commisso B, Ding L, Varadi K, Gorges M, Bayer D, Boeckers TM, Ludolph AC, Kassubek J, Müller OJ, Roselli F.

Elife. 2018 Aug 23;7. pii: e36892. doi: 10.7554/eLife.36892.

17.

[Parkinson Disease and Pain - diagnostic and therapeutic approaches to a challenging non-motor symptom].

Buhmann C, Ip CW, Oehlwein C, Tönges L, Wolz M, Reichmann H, Kassubek J.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S48-S58. doi: 10.1055/a-0590-4464. Epub 2018 Jul 17. German.

PMID:
30016807
18.

Response letter: Retinal changes in patients with major depressive disorder - a controlled optical coherence tomography study.

Schönfeldt-Lecuona C, Schmidt A, Kregel T, Kassubek J, Dreyhaupt J, Freudenmann RW, Connemann BJ, Pinkhardt EH, Gahr M.

J Affect Disord. 2018 Oct 15;239:123. doi: 10.1016/j.jad.2018.06.049. Epub 2018 Jun 30. No abstract available.

PMID:
29990659
19.

MRI-based neuroimaging: atypical parkinsonisms and other movement disorders.

Kassubek J.

Curr Opin Neurol. 2018 Aug;31(4):425-430. doi: 10.1097/WCO.0000000000000578.

PMID:
29952835
20.

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.

Ludolph AC, Schuster J, Dorst J, Dupuis L, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Petri S, Meyer T, Grosskreutz J, Schrank B, Boentert M, Emmer A, Hermann A, Zeller D, Prudlo J, Winkler AS, Grehl T, Heneka MT, Wollebæk Johannesen S, Göricke B; RAS-ALS Study Group.

Lancet Neurol. 2018 Aug;17(8):681-688. doi: 10.1016/S1474-4422(18)30176-5. Epub 2018 Jun 19.

PMID:
29934198
21.

Structural and Functional Brain Mapping Correlates of Impaired Eye Movement Control in Parkinsonian Syndromes: A Systems-Based Concept.

Gorges M, Müller HP, Kassubek J.

Front Neurol. 2018 May 7;9:319. doi: 10.3389/fneur.2018.00319. eCollection 2018. Review.

22.

Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study.

Müller HP, Gorges M, Kassubek R, Dorst J, Ludolph AC, Kassubek J.

Neuroimage Clin. 2018 Mar 15;18:762-769. doi: 10.1016/j.nicl.2018.03.018. eCollection 2018.

23.

Alpha-synuclein is present in dental calculus but not altered in Parkinson's disease patients in comparison to controls.

Schmid S, Goldberg-Bockhorn E, Schwarz S, Rotter N, Kassubek J, Del Tredici K, Pinkhardt E, Otto M, Ludolph AC, Oeckl P.

J Neurol. 2018 Jun;265(6):1334-1337. doi: 10.1007/s00415-018-8847-2. Epub 2018 Mar 29.

PMID:
29600388
24.

Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients - An Atlas-Based Volumetric MRI Study.

Schönecker S, Neuhofer C, Otto M, Ludolph A, Kassubek J, Landwehrmeyer B, Anderl-Straub S, Semler E, Diehl-Schmid J, Prix C, Vollmar C, Fortea J; Deutsches FTLD-Konsortium, Huppertz HJ, Arzberger T, Edbauer D, Feddersen B, Dieterich M, Schroeter ML, Volk AE, Fließbach K, Schneider A, Kornhuber J, Maler M, Prudlo J, Jahn H, Boeckh-Behrens T, Danek A, Klopstock T, Levin J.

Front Aging Neurosci. 2018 Mar 15;10:45. doi: 10.3389/fnagi.2018.00045. eCollection 2018.

25.

Longitudinal Diffusion Tensor Imaging Resembles Patterns of Pathology Progression in Behavioral Variant Frontotemporal Dementia (bvFTD).

Kassubek J, Müller HP, Del Tredici K, Hornberger M, Schroeter ML, Müller K, Anderl-Straub S, Uttner I, Grossman M, Braak H, Hodges JR, Piguet O, Otto M, Ludolph AC.

Front Aging Neurosci. 2018 Mar 6;10:47. doi: 10.3389/fnagi.2018.00047. eCollection 2018.

26.

Ventral Striatal D2/3 Receptor Availability Is Associated with Impulsive Choice Behavior As Well As Limbic Corticostriatal Connectivity.

Barlow RL, Gorges M, Wearn A, Niessen HG, Kassubek J, Dalley JW, Pekcec A.

Int J Neuropsychopharmacol. 2018 Jul 1;21(7):705-715. doi: 10.1093/ijnp/pyy030.

27.

Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis.

Lulé D, Böhm S, Müller HP, Aho-Özhan H, Keller J, Gorges M, Loose M, Weishaupt JH, Uttner I, Pinkhardt E, Kassubek J, Del Tredici K, Braak H, Abrahams S, Ludolph AC.

Cortex. 2018 Apr;101:163-171. doi: 10.1016/j.cortex.2018.01.004. Epub 2018 Jan 31.

PMID:
29477906
28.

The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy.

Rosenbohm A, Hirsch S, Volk AE, Grehl T, Grosskreutz J, Hanisch F, Herrmann A, Kollewe K, Kress W, Meyer T, Petri S, Prudlo J, Wessig C, Müller HP, Dreyhaupt J, Weishaupt J, Kubisch C, Kassubek J, Weydt P, Ludolph AC.

J Neurol. 2018 May;265(5):1026-1036. doi: 10.1007/s00415-018-8790-2. Epub 2018 Feb 20.

PMID:
29464380
29.

In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis.

Abdelhak A, Hübers A, Böhm K, Ludolph AC, Kassubek J, Pinkhardt EH.

J Neurol. 2018 Apr;265(4):949-953. doi: 10.1007/s00415-018-8787-x. Epub 2018 Feb 20.

PMID:
29464376
30.

Dietary pattern associated with selenoprotein P and MRI-derived body fat volumes, liver signal intensity, and metabolic disorders.

di Giuseppe R, Plachta-Danielzik S, Koch M, Nöthlings U, Schlesinger S, Borggrefe J, Both M, Müller HP, Kassubek J, Jacobs G, Lieb W.

Eur J Nutr. 2018 Feb 14. doi: 10.1007/s00394-018-1624-2. [Epub ahead of print]

PMID:
29445913
31.

Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.

Rosenbohm A, Liu M, Nagel G, Peter RS, Cui B, Li X, Kassubek J, Rothenbacher D, Lulé D, Cui L, Ludolph AC; ALS Registry Swabia Study Group.

J Neurol. 2018 Apr;265(4):774-782. doi: 10.1007/s00415-018-8735-9. Epub 2018 Feb 1.

PMID:
29392461
32.

Hyperconnective and hypoconnective cortical and subcortical functional networks in multiple system atrophy.

Rosskopf J, Gorges M, Müller HP, Pinkhardt EH, Ludolph AC, Kassubek J.

Parkinsonism Relat Disord. 2018 Apr;49:75-80. doi: 10.1016/j.parkreldis.2018.01.012. Epub 2018 Jan 12.

PMID:
29352721
33.

Longitudinal Diffusion Tensor Imaging-Based Assessment of Tract Alterations: An Application to Amyotrophic Lateral Sclerosis.

Baldaranov D, Khomenko A, Kobor I, Bogdahn U, Gorges M, Kassubek J, Müller HP.

Front Hum Neurosci. 2017 Dec 5;11:567. doi: 10.3389/fnhum.2017.00567. eCollection 2017.

34.

Retinal changes in patients with major depressive disorder - A controlled optical coherence tomography study.

Schönfeldt-Lecuona C, Schmidt A, Kregel T, Kassubek J, Dreyhaupt J, Freudenmann RW, Connemann BJ, Pinkhardt EH, Gahr M.

J Affect Disord. 2018 Feb;227:665-671. doi: 10.1016/j.jad.2017.11.077. Epub 2017 Nov 16.

PMID:
29174740
35.

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression.

Steinacker P, Verde F, Fang L, Feneberg E, Oeckl P, Roeber S, Anderl-Straub S, Danek A, Diehl-Schmid J, Fassbender K, Fliessbach K, Foerstl H, Giese A, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer GB, Lauer M, Pinkhardt EH, Prudlo J, Rosenbohm A, Schneider A, Schroeter ML, Tumani H, von Arnim CAF, Weishaupt J, Weydt P, Ludolph AC, Yilmazer Hanke D, Otto M; FTLDc study group.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):239-247. doi: 10.1136/jnnp-2017-317138. Epub 2017 Nov 15.

PMID:
29142138
36.

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker.

Kassubek J, Müller HP, Del Tredici K, Lulé D, Gorges M, Braak H, Ludolph AC.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):374-381. doi: 10.1136/jnnp-2017-316365. Epub 2017 Nov 3.

37.

Fast progressive lower motor neuron disease is an ALS variant: A two-centre tract of interest-based MRI data analysis.

Müller HP, Agosta F, Riva N, Spinelli EG, Comi G, Ludolph AC, Filippi M, Kassubek J.

Neuroimage Clin. 2017 Oct 14;17:145-152. doi: 10.1016/j.nicl.2017.10.008. eCollection 2018.

38.

Association of Vitamin E Levels with Metabolic Syndrome, and MRI-Derived Body Fat Volumes and Liver Fat Content.

Waniek S, di Giuseppe R, Plachta-Danielzik S, Ratjen I, Jacobs G, Koch M, Borggrefe J, Both M, Müller HP, Kassubek J, Nöthlings U, Esatbeyoglu T, Schlesinger S, Rimbach G, Lieb W.

Nutrients. 2017 Oct 18;9(10). pii: E1143. doi: 10.3390/nu9101143.

39.

Cardiac Findings in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Imaging Study.

Rosenbohm A, Schmid B, Buckert D, Rottbauer W, Kassubek J, Ludolph AC, Bernhardt P.

Front Neurol. 2017 Sep 27;8:479. doi: 10.3389/fneur.2017.00479. eCollection 2017.

40.

Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.

Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, Nagel G, Ludolph AC.

Eur J Epidemiol. 2017 Oct;32(10):901-908. doi: 10.1007/s10654-017-0318-z. Epub 2017 Oct 3.

PMID:
28975435
41.

GFAP in early multiple sclerosis: A biomarker for inflammation.

Kassubek R, Gorges M, Schocke M, Hagenston VAM, Huss A, Ludolph AC, Kassubek J, Tumani H.

Neurosci Lett. 2017 Sep 14;657:166-170. doi: 10.1016/j.neulet.2017.07.050. Epub 2017 Aug 9.

PMID:
28802830
42.

Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes.

Gorges M, Maier MN, Rosskopf J, Vintonyak O, Pinkhardt EH, Ludolph AC, Müller HP, Kassubek J.

J Neurol. 2017 Sep;264(9):1919-1928. doi: 10.1007/s00415-017-8579-8. Epub 2017 Jul 31.

PMID:
28762086
43.

Cerebral Microstructural Alterations after Radiation Therapy in High-Grade Glioma: A Diffusion Tensor Imaging-Based Study.

Kassubek R, Gorges M, Westhoff MA, Ludolph AC, Kassubek J, Müller HP.

Front Neurol. 2017 Jun 15;8:286. doi: 10.3389/fneur.2017.00286. eCollection 2017.

44.

Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis.

Keller J, Böhm S, Aho-Özhan HEA, Loose M, Gorges M, Kassubek J, Uttner I, Abrahams S, Ludolph AC, Lulé D.

Brain Imaging Behav. 2018 Jun;12(3):771-784. doi: 10.1007/s11682-017-9738-3.

PMID:
28600740
45.

Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis.

Gorges M, Vercruysse P, Müller HP, Huppertz HJ, Rosenbohm A, Nagel G, Weydt P, Petersén Å, Ludolph AC, Kassubek J, Dupuis L.

J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1033-1041. doi: 10.1136/jnnp-2017-315795. Epub 2017 Jun 8.

PMID:
28596251
46.

Reply to: MRI measures of brainstem in parkinsonian syndromes: Where we stand and where we need to go.

Kassubek J, Huppertz HJ, Höglinger GU.

Mov Disord. 2017 Aug;32(8):1261-1262. doi: 10.1002/mds.27057. Epub 2017 Jun 7. No abstract available.

PMID:
28590575
47.

Intrinsic functional connectivity alterations in progressive supranuclear palsy: Differential effects in frontal cortex, motor, and midbrain networks.

Rosskopf J, Gorges M, Müller HP, Lulé D, Uttner I, Ludolph AC, Pinkhardt E, Juengling FD, Kassubek J.

Mov Disord. 2017 Jul;32(7):1006-1015. doi: 10.1002/mds.27039. Epub 2017 May 22.

PMID:
28544256
48.

Functional Connectivity Mapping in the Animal Model: Principles and Applications of Resting-State fMRI.

Gorges M, Roselli F, Müller HP, Ludolph AC, Rasche V, Kassubek J.

Front Neurol. 2017 May 10;8:200. doi: 10.3389/fneur.2017.00200. eCollection 2017. Review.

49.

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU; Movement Disorder Society-Endorsed PSP Study Group.

Mov Disord. 2017 Jul;32(7):995-1005. doi: 10.1002/mds.27034. Epub 2017 May 13. Review.

50.

Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe LI, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2017 Jul;32(7):955-971. doi: 10.1002/mds.27038. Epub 2017 May 13. Review.

Supplemental Content

Loading ...
Support Center